株探米国株
英語
エドガーで原本を確認する
0001550695FALSE00015506952024-04-262024-04-26

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 26, 2024 
 
Performant Financial Corporation
(Exact name of registrant as specified in its charter)

Delaware   001-35628   20-0484934
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)
900 South Pine Island Road,
Plantation, FL 33324
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (925)  960-4800

N/A
(Former name or former address, if changed since last report.)
 
 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)  Name of exchange on which registered
Common Stock, par value $.0001 per share
PFMT
The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).     

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Chief Executive Officer
Simeon M. Kohl has served as the Chief Executive Officer of Performant Financial Corporation (the “Company”) since May 2023. Prior to his appointment as the Company’s Chief Executive Officer, Mr. Kohl served as the Company’s President from March 2022 to May 2023, and prior to that, Mr. Kohl served as the Company’s Vice President of Healthcare and Vice President of Sales and Account Management from February 2012 to March 2022. Mr. Kohl has more than 20 years of executive management experience and an extensive background in healthcare cost containment and related services.
In connection with Kohl’s appointment as the Company’s Chief Executive Officer, on April 26, 2024, the Company entered into an Employment Agreement with Mr. Kohl, effective May 5, 2023 (the “Kohl Employment Agreement”). Under the terms of the Kohl Employment Agreement, Mr. Kohl is entitled to an annual base salary of $345,000 and will have a target annual bonus opportunity of 75% of his annual base salary with the amount earned, if any, based on the achievement of one or more milestones to be established each year by our board of directors, subject to his continuous employment on the last day of the applicable calendar year. In addition, pursuant to the Kohl Employment Agreement, in connection with his appointment as our Chief Executive Officer, Mr. Kohl was granted two (2) restricted stock unit (“RSU”) awards under the Company’s 2012 Stock Incentive Plan. On May 5,2023, Mr. Kohl was granted an RSU award with respect to 366,898 shares of the Company’s common stock with (i) fifty-percent (50%) of the RSUs vesting in four (4) equal installments on each of the first four (4) anniversaries of May 5, 2023, subject to Mr. Kohl’s continued employment on each such date, and (ii) the remaining fifty-percent (50%) of the RSUs vesting subject to performance-based vesting conditions based on predetermined target prices for shares of the Company’s common stock. The Kohl Employment Agreement contains customary confidentiality and intellectual property assignment provisions.
Concurrently with the execution of the Kohl Employment Agreement, the Company entered into its form of indemnification agreement with Mr. Kohl. Mr. Kohl has no family relationships with any of the Company’s directors or executive officers, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Contemporaneously with the execution of the Kohl Employment Agreement, the Company entered into a Change in Control and Severance Agreement with Mr. Kohl (the “Kohl Severance Agreement”). The Kohl Severance Agreement will terminate on April 26, 2027, unless mutually renewed by the parties. Under the Kohl Severance Agreement, in the event Mr. Kohl is either employed at the time of a change in control (as defined in the Kohl Severance Agreement) or his employment terminates as a result of an involuntary termination (as defined in the Kohl Severance Agreement) on or within three (3) months prior to a change in control, subject to his execution of a general release of claims and continued compliance with certain restrictive covenants, all of Mr. Kohl’s equity awards subject to vesting based on performance shall be treated as follows: (i) in the case of a performance-based equity award where performance is measured against the Company’s stock price or similar market-based performance criteria, the performance-based equity award will fully accelerate, (ii) in the case of a performance-based equity award where performance is measured against a business performance metric that is not measured against the Company’s stock price or similar market-based metric, such performance criteria will be deemed satisfied at 100% of target for any unfinished performance period and such performance-based equity award will convert to time based vesting on a ratable basis for the remainder of the original performance period, and (iii) any performance-based equity award for which the performance condition is not deemed satisfied will be forfeited, in each case, effective as of the date of the consummation of the change in control.
Pursuant to the Kohl Severance Agreement, in the event that Mr. Kohl’s employment terminates as a result of an involuntary termination either on or at any time within twelve months (12) months after a change in control, or within three (3) months prior to a change in control, subject to his execution of a general release of claims and continued compliance with certain restrictive covenants, Mr. Kohl will become entitled to the following severance benefits: (i) a severance payment equal to the sum of one hundred fifty percent (150%) of his then current annual base salary and target bonus, payable in a lump sum on the sixtieth (60th) day following the termination date, (ii) all of Mr. Kohl’s then outstanding equity awards subject to time-base vesting (including any performance-based equity awards that were converted into time-based equity awards upon the change in control) will become fully vested and exercisable, and (iii) a lump sum payment equal to eighteen (18) months of premiums under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, or corresponding provision of state law (“COBRA”) for health insurance coverage for Mr. Kohl and his eligible dependents, at the same level and for the same eligible dependents covered as of his termination date.



Further pursuant to the Kohl Severance Agreement, in the event Mr. Kohl’s employment terminates as a result of an involuntary termination that occurs more than three (3) months prior to or twelve (12) months after a change in control, subject to his execution of a general release of claims and continued compliance with certain restrictive covenants, Mr. Kohl will become entitled to the following severance benefits: (i) one hundred percent (100%) of his then current annual base salary and target bonus, payable in a lump sum on the sixtieth (60th) day following the termination date, and (ii) a lump sum payment equal to twelve (12) months of premiums under COBRA for health insurance coverage for Mr. Kohl and his eligible dependents, at the same level and for the same eligible dependents covered as of his termination date.
Chief Financial Officer
Rohit Ramchandani has served as the Company’s Chief Financial Officer since May 2023. Prior to his appointment as Chief Financial Officer, Mr. Ramchandani served as the Company’s Senior Vice President of Finance and Strategy in addition to a variety of roles at the Company from March 2014 to May 2023. With a background in finance, Mr. Ramchandani has over a decade of financial strategy and operations experience. Mr. Ramchandani holds a Bachelor of Science in Business Administration and a Bachelor of Science in Economics/Mathematics, both from the University of Southern California.
In connection with Ramchandani’s appointment as the Company’s Chief Financial Officer, on April 26, 2024, the Company entered into an Employment Agreement with Mr. Ramchandani, effective May 5, 2023 (the “Ramchandani Employment Agreement”). Under the terms of the Ramchandani Employment Agreement, Mr. Ramchandani is entitled to an annual base salary of $290,000 and will have a target annual bonus opportunity of 50% of his annual base salary with the amount earned, if any, based on the achievement of one or more milestones to be established each year by our board of directors, subject to his continuous employment on the last day of the applicable calendar year. In addition, pursuant to the Ramchandani Employment Agreement, in connection with his appointment as our Chief Financial Officer, Mr. Ramchandani was granted an RSU award with respect to 216,724 shares of the Company’s common stock with (i) fifty-percent (50%) of the RSUs vesting in four (4) equal installments on each of the first four (4) anniversaries of May 4, 2023, subject to Mr. Ramchandani’s continued employment on each such date, and (ii) the remaining fifty-percent (50%) of the RSUs vesting subject to performance-based vesting conditions based on predetermined target prices for shares of the Company’s common stock. On March 26, 2024, Mr. Ramchandani was granted an RSU award with respect to 52,817 shares of the Company’s common stock with such award vesting in four equal installments on each of the first four anniversaries of the grant date of such award, subject to Mr. Ramchandani’s continued employment on each such date. The Ramchandani Employment Agreement contains customary confidentiality and intellectual property assignment provisions.
Concurrently with the execution of the Ramchandani Employment Agreement, the Company entered into its form of indemnification agreement with Mr. Ramchandani. Mr. Ramchandani has no family relationships with any of the Company’s directors or executive officers, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Contemporaneously with the execution of the Ramchandani Employment Agreement, the Company entered into a Change in Control and Severance Agreement with Mr. Ramchandani (the “Ramchandani Severance Agreement”). The Ramchandani Severance Agreement will terminate on April 26, 2027, unless mutually renewed by the parties. Under the Ramchandani Severance Agreement, in the event Mr. Ramchandani is either employed at the time of a change in control (as defined in the Ramchandani Severance Agreement) or his employment terminates as a result of an involuntary termination (as defined in the Ramchandani Severance Agreement) on or within three (3) months prior to a change in control, subject to his execution of a general release of claims and continued compliance with certain restrictive covenants, all of Mr. Ramchandani’s equity awards subject to vesting based on performance shall be treated as follows: (i) in the case of a performance-based equity award where performance is measured against the Company’s stock price or similar market-based performance criteria, the performance-based equity award will fully accelerate, (ii) in the case of a performance-based equity award where performance is measured against a business performance metric that is not measured against the Company’s stock price or similar market-based metric, such performance criteria will be deemed satisfied at 100% of target for any unfinished performance period and such performance-based equity award will convert to time based vesting on a ratable basis for the remainder of the original performance period, and (iii) any performance-based equity award for which the performance condition is not deemed satisfied will be forfeited, in each case, effective as of the date of the consummation of the change in control.



Pursuant to the Ramchandani Severance Agreement, in the event that Mr. Ramchandani’s employment terminates as a result of an involuntary termination either on or at any time within twelve months (12) months after a change in control, or within three (3) months prior to a change in control, subject to his execution of a general release of claims and continued compliance with certain restrictive covenants, Mr. Ramchandani will become entitled to the following severance benefits: (i) a severance payment equal to the sum of one hundred percent (100%) of his then current annual base salary and target bonus, payable in a lump sum on the sixtieth (60th) day following the termination date, (ii) all of Mr. Ramchandani’s then outstanding equity awards subject to time-base vesting (including any performance-based equity awards that were converted into time-based equity awards upon the change in control) will become fully vested and exercisable, and (iii) a lump sum payment equal to twelve (12) months of premiums under COBRA for health insurance coverage for Mr. Ramchandani and his eligible dependents, at the same level and for the same eligible dependents covered as of his termination date.
Further pursuant to the Ramchandani Severance Agreement, in the event Mr. Ramchandani’s employment terminates as a result of an involuntary termination that occurs more than three (3) months prior to or twelve (12) months after a change in control, subject to his execution of a general release of claims and continued compliance with certain restrictive covenants, Mr. Ramchandani will become entitled to the following severance benefits: (i) seventy-five percent (75%) of his then current annual base salary and target bonus, payable in a lump sum on the sixtieth (60th) day following the termination date, and (ii) a lump sum payment equal to nine (9) of premiums under COBRA for health insurance coverage for Mr. Ramchandani and his eligible dependents, at the same level and for the same eligible dependents covered as of his termination date.
The foregoing descriptions of the Kohl Employment Agreement, Kohl Severance Agreement, Ramchandani Employment Agreement and Ramchandani Severance Agreement are not intended to be complete and are qualified in their entirety by reference to the applicable agreements, which are attached hereto as Exhibits 10.1, 10.2, 10.3 and 10.4 respectively and are incorporated hereby by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
Description
10.1#
10.2#
10.3#
10.4#
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
# Indicates management contract or compensatory plan or arrangement.



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: May 1, 2024
 
PERFORMANT FINANCIAL CORPORATION
By:   /s/Simeon Kohl
  Simeon Kohl
  Chief Executive Officer

EX-10.1 2 pfmt-employmentagreementko.htm EX-10.1 Document
Exhibit 10.1
EMPLOYMENT AGREEMENT
This Employment Agreement (the “Agreement”) is entered into by and between Performant Financial Corporation, a Delaware corporation (the “Company”) and Simeon Kohl (the “Executive”) dated as of April 26, 2024.
1.Position; Place of Work. Effective as of May 5, 2023 (the “Effective Date”) the Executive shall serve as the Company’s Chief Executive Officer (“CEO”), and also agrees to serve, if appointed or elected, as an officer or director of any other affiliate of the Company.
2.Duties and Responsibilities. The Executive's primary duties and responsibilities will be those generally associated with the position of CEO, reporting to the Board of Directors of the Company (the “Board”). The Executive shall perform such other duties as he may be assigned from time to time by the “Board”. The Executive agrees to abide by the rules, regulations, personnel practices and policies of the Company and, as applicable, its affiliates, and any changes therein that may be adopted by them from time to time.
3.Devotion of Time to Business. The Executive shall devote such of the Executive’s professional time to the Executive’s employment as may be required to perform services hereunder and shall expend his best efforts on behalf of the Company.
4.Conflicts of Interest. In order to avoid conflicts of interest and inadvertent disclosure or improper use of Confidential information and to ensure that the Executive devotes his professional energies to his employment, while employed by the Company the Executive will not accept or engage in any professional employment, consulting or other service relationship with any business without first giving written notice to, and receiving written approval from, the Board.
5.Compensation.
a.Base Salary. As of the Effective Date, the Executive’s base salary shall be $345,000 per year on an annualized basis (“Base Salary”), which will be paid to the Executive in accordance with the Company’s normal payroll procedures.
b.Bonus. As of the Effective Date, the Executive’s target annual bonus (the “Performance Bonus”) will be 75% of the Executive’s Base Salary. The Performance Bonus will be earned by the achievement of one or more milestones to be set each year by the Board. The allocation of the Bonus to the various milestones and the terms on which the Performance Bonus will be earned will be set by the Board in its sole discretion. In order to earn any or all of the Performance Bonus for any given the Executive must be employed on the last day of the calendar year. The Performance Bonus will be paid on or before March 15 of the year following the year in which it is earned. If the Board does not pass a resolution establishing milestones and the allocation of the Performance Bonus by the end of the first quarter of any calendar year, the Performance Bonus for that year will be a discretionary Bonus.



c.Equity Award. The Executive and the Company acknowledge that in connection with his promotion to CEO, the Executive received a restricted stock unit award under the Company’s 2012 Stock Incentive Plan covering 366,898 shares of the Company’s common stock (the “RSU Award”), with (i) fifty-percent (50%) of the RSU Award vesting in four equal installments on each of the first four anniversaries of the Effective Date, subject to the Executive’s continued employment on each such date, and (ii) the remaining fifty-percent (50%) of the RSU Award subject to performance-based vesting conditions based on predetermined target prices for shares of the Company’s common stock. The Executive will also be eligible for future grants of equity compensation in the sole discretion of the Board or the Compensation Committee of the Board.
6.Benefits.
a.General. The Executive will be entitled to participate in all Company sponsored benefit and insurance programs to the extent that such benefits are offered generally to the Company’s employees in similar positions, with similar seniority. The terms of the Company’s benefit plans and programs are subject to change at any time in the Company’s sole discretion.
b.Term Life Insurance. The Company shall purchase a term life insurance policy insuring the life of the Executive with a death benefit of $1,000,000. The obligation of the Company to purchase such policy shall be conditioned on the Executive's successful completion of any required medical examination(s) such that the policy can be bought at standard rates, and an annual premium not in excess of $3,500. The Executive shall, in his sole discretion, name the beneficiaries of the policy.
c.Expenses. The Company shall reimburse the Executive, in accordance with the Company's policy, for all reasonable expenses incurred by the Executive in connection with the performance of the Executive's duties. Reimbursement will be made within thirty (30) days of submission of a properly completed expense report with all receipts, but no later than March 15 of the year following the year in which such expense was incurred and the report submitted.
d.Paid Time Off. The Executive will be entitled to four weeks (20 days) paid vacation days per year. The Executive’s accrued paid vacation will be capped at 1.5 times his annual accrual. Once the Executive has hit the accrual cap, he will not accrue more vacation until he has reduced his accrued paid time off below the maximum accrual. Sick pay accrual will be in accordance with company policy.
7.Confidential Information and Assignment to Company of Inventions. Prior to or contemporaneous with the execution of this Agreement the Executive has executed a Proprietary Information, Non-Competition and Inventions Assignment Agreement (the “IP Agreement”). Notwithstanding anything else contained herein, nothing in this Agreement is intended to or shall be construed to modify, impair or terminate any obligation of the Executive pursuant to the IP Agreement.
2


8.At-Will Employment. The Executive’s employment is “at-will.” This means that either the Executive or the Company may terminate the Executive’s employment under this Agreement at any time, with or without cause and with or without notice.
9.Change in Control and Severance Agreement. The Executive and the Company shall enter into a separate Change in Control and Severance Agreement contemporaneously with the execution of this Agreement.
10.Withholdings. All compensation payable to the Executive shall be subject to applicable taxes and withholdings.
11.Severability. The invalidity or unenforceability of any provision(s) of this Agreement under particular facts and circumstances will not affect the validity or enforceability either of other provisions of this Agreement or, under other facts and circumstances, of such provision(s). In addition, such provision(s) will be reformed to be less restrictive if under such facts and circumstances they would then be valid and enforceable.
12.Indemnification. The Executive will be provided indemnification to the maximum extent permitted by the Company’s Certificate of Incorporation or Bylaws, including, if applicable, any directors and officers insurance policies, with such indemnification to be on terms determined by the Board or any of its committees, but on terms no less favorable than provided to any other Company executive officer or director. Concurrently with the execution of this Agreement, the Company and the Executive will also enter into the Company’s standard form of indemnification agreement.
13.Sole and Only Agreement. This Agreement contains a complete statement of all agreements between the parties hereto with respect to its subject matter and except as expressly set forth herein supersedes all previous agreements, arrangements and understandings, written or oral, relating to its subject matter and cannot be changed or terminated except in writing, signed by the Executive and the Company.
14.Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Florida.
15.No Waiver of Rights. The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver or deprive that party of the right thereafter to insist upon adherence to that term or any other term of this Agreement. The waiver of a term or condition must be in writing executed by the party against whom the waiver is asserted.
16.Assignment of Rights. The Executive expressly acknowledges and agrees that Company’s rights under this Agreement may be transferred to or assigned by Company to a successor employer.
3


17.Consent to Arbitration. Except as prohibited by law, each party to this Agreement agrees that, any claim, controversy or legal dispute between them or between The Executive and any officer, director, shareholder, agent or employee of the Company, each of whom is hereby designated a third party beneficiary of this agreement regarding arbitration, (a "Dispute") arising out of the Executive's employment or termination of such employment or this Agreement will be resolved through binding arbitration in Miami, Florida in accordance with the then current Employment Arbitration Rules and Procedures Rules (the “Rules”) of the JAMS, Inc. which Rules are available for review at www.jamsadr.com and are incorporated herein by reference. Judgment upon the award rendered by the arbitrator in such proceeding may be entered in any court having jurisdiction thereof, provided, however, that the Law applicable to any issues regarding the scope, effectiveness or interpretation of this arbitration provision shall be the Federal Arbitration Act. This includes any claims the Executive may make relating to alleged discrimination or harassment during employment based on race, color, national origin, religion, disability, age, gender or sexual orientation, any claims relating to compensation (wages, bonuses, benefits, etc.) and any claims under federal state, or local laws or regulations relating to terms and conditions of employment. THE PARTIES HERETO UNDERSTAND THAT BY AGREEING TO ARBITRATE DISPUTES THEY ARE WAIVING ANY RIGHT TO A JURY TRIAL. The parties hereto agree that such arbitration shall be conducted on an individual basis only, not a class, representative or collective basis, and hereby waive any right to bring class wide, collective or representative claims before any arbitrator or in any forum. This arbitration provision is not intended to modify or limit the remedies available to either party, including the right to seek interim relief, such as injunction or attachment, through judicial process, which will not be deemed a waiver of the right to demand and obtain arbitration.
18.Attorneys’ Fees. In the event of any such arbitration or other legal proceeding, the prevailing party shall recover his or its reasonable attorneys' fees, except expenses, and costs, excluding arbitration fees, to the extent permitted by law.
[Remainder of page intentionally left blank]
4


In Witness Whereof, the parties hereto have executed this Agreement.
PERFORMANT FINANCIAL CORPORATION
By: /s/ Lisa Im
Name: Lisa Im
Title: Executive Chair
Date:
EXECUTIVE:
/s/ Simeon Kohl
Simeon Kohl
Date:


EX-10.2 3 pfmt-changeincontrolandsev.htm EX-10.2 Document
Exhibit 10.2
PERFORMANT FINANCIAL CORPORATION
CHANGE IN CONTROL AND SEVERANCE AGREEMENT
This Change in Control Severance Agreement (this “Agreement”) is made and entered into effective as of April 26, 2024 (the “Effective Date”), by and between Simeon Kohl (“Executive”) and Performant Financial Corporation, a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1 below.
RECITALS
A.    It is expected that the Company from time to time will consider the possibility of a Change in Control. The Board of Directors of the Company (the “Board”) recognizes that such consideration can be a distraction to Executive and can cause Executive to consider alternative employment opportunities.
B.    The Board believes that it is in the best interests of the Company and its shareholders to provide Executive with an incentive to continue Executive’s employment and to maximize the value of the Company upon a Change in Control for the benefit of its shareholders.
C.    In order to provide Executive with enhanced financial security and sufficient encouragement to remain with the Company notwithstanding the possibility of a Change in Control, the Board believes that it is imperative to provide Executive with certain severance and other benefits upon Executive’s termination of employment in connection with a Change in Control.
D.    The Board also believes it is in the best interests of the Company and its shareholders to provide Executive with severance upon an involuntary termination other than in connection with a Change in Control.
AGREEMENT
In consideration of the mutual covenants herein contained and the continued employment of Executive by the Company, the parties agree as follows:
1.Definition of Terms. The following terms referred to in this Agreement shall have the following meanings:
(a)Cause. “Cause” shall mean Executive’s (i) commission of a felony, an act involving moral turpitude, or an act constituting common law fraud, and which has an adverse effect on the business or affairs of the Company or its affiliates or stockholders; (ii) intentional or willful misconduct or refusal to follow the lawful instructions of the Board that is not cured within thirty (30) days following written notice from the Board; (iii) commission of any violation of a company policy that has a material adverse effect on the business or reputation of the Company or (iv) intentional breach of Company confidential information obligations which has an adverse effect on the Company or its affiliates or stockholders. For these purposes, no act or failure to act shall be considered “intentional or willful” unless it is done, or omitted to be done,




in bad faith without a reasonable belief that the action or omission is in the best interests of the Company.
(b)Change in Control. “Change in Control” shall mean the occurrence of any of the following events:
(i)A change in the composition of the Board occurs, as a result of which fewer than one-half of the incumbent directors are directors who either:
(A)had been directors of the Company on the “look-back date” (as defined below) (the “original directors”); or
(B)were elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the aggregate of the original directors who were still in office at the time of the election or nomination and the directors whose election or nomination was previously so approved (the “continuing directors”);
provided, however, that for this purpose, the “original directors” and “continuing directors” shall not include any individual whose initial assumption of office occurred as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents, by or on behalf of a person other than the Board; or
(ii)Any “person” (as defined below) who by the acquisition or aggregation of securities, is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934 (the “Exchange Act”)), directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company’s then outstanding securities ordinarily (and apart from rights accruing under special circumstances) having the right to vote at elections of directors (the “Base Capital Stock”); except that any change in the relative beneficial ownership of the Company’s securities by any person resulting solely from a reduction in the aggregate number of outstanding shares of Base Capital Stock, and any decrease thereafter in such person’s ownership of securities, shall be disregarded until such person increases in any manner, directly or indirectly, such person’s beneficial ownership of any securities of the Company; or
(iii)the consummation of a merger or consolidation of the Company or a Subsidiary of the Company with or into another entity or any other corporate reorganization, if persons who were not stockholders of the Company immediately prior to such merger, consolidation or other reorganization own immediately after such merger, consolidation or other reorganization 50% or more of the voting power of the outstanding securities of each of:
(A)the Company (or its successor) and
(B)any direct or indirect parent corporation of the Company (or its successor); or
2



(iv)The sale, transfer or other disposition of all or substantially all of the Company’s assets.
For purposes of subsection 1(b)(i) above, the term “look-back date” shall mean the date 24 months prior to the date of the event that may constitute a Change in Control.
For purposes of subsection 1(b)(ii)) above, the term “person” shall have the same meaning as when used in Sections 13(d) and 14(d) of the Exchange Act but shall exclude (1) a trustee or other fiduciary holding securities under an employee benefit plan maintained by the Company or a parent or subsidiary and (2) a corporation owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the stock.
Any other provision of this Section 1(b) notwithstanding, a transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company’s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction, and a Change in Control shall not be deemed to occur if the Company files a registration statement with the United States Securities and Exchange Commission for the initial or secondary public offering of securities or debt of the Company to the public.
(c)Disability. “Disability” shall mean “disability” within the meaning of Section 22(e)(3) of the Code
(d)Equity Award. “Equity Award” shall mean Executive’s awards of options, stock appreciation rights, restricted shares or stock units with respect to the Company or its successor, or the direct or indirect parent of either, or of any deferred compensation into which such stock options, stock appreciation rights, restricted shares or stock units were converted upon or prior to a Change in Control.
(e)Involuntary Termination. “Involuntary Termination” shall mean:
(i)a material reduction in Executive’s title, duties, authorities or responsibilities as the Chief Executive Officer of the Company without the Executive’s express written consent;
(ii)without Executive’s express written consent, a reduction by the Company of Executive’s base compensation of more than ten percent (10%), unless such reduction in base compensation is part of a general reduction in compensation applicable to senior executives of the Company;
(iii)without Executive’s express written consent, the relocation of Executive’s principal place of employment to a facility or a location more than fifty (50) miles from its location as of the Effective Date or, on or following a Change in Control, from its location immediately prior to such Change in Control; provided that Executive may not claim an Involuntary Termination if he is permitted to work remotely;
3



(iv)any termination of Executive by the Company which is not effected for Cause; or
(v)the failure of the Company to obtain the assumption of this Agreement or any other agreement between the Company and Executive by any successors contemplated in Section 10 below.
A termination shall not be considered an “Involuntary Termination” unless Executive provides notice to the Company of the existence of the condition described in subsections (i), (ii), (iii) or (iv) above within ninety (90) days of the initial existence of such condition, the Company fails to remedy the condition within thirty (30) days following the receipt of such notice, and Executive terminates employment within one-hundred eighty (180) days following the initial existence of such condition. A termination due to death or Disability shall not be considered an Involuntary Termination.
(f)Termination Date. “Termination Date” shall mean Executive’s “separation from service” within the meaning of that term under Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”).
2.Term of Agreement. This Agreement shall terminate on the third anniversary of the Effective Date, unless mutually renewed by the parties.
3.At-Will Employment. The Company and Executive acknowledge that Executive’s employment is and shall continue to be at-will, as defined under applicable law.
4.Change in Control Related Benefits.
(a)Effect of Change in Control on Performance-Based Equity Awards. If Executive is either employed at the time of a Change in Control or Executive’s employment with the Company terminates as a result of an Involuntary Termination on or within three (3) months prior to a Change in Control, and provided that in the case of such Involuntary Termination the Executive signs and does not revoke a release in a form approved by the Company (a “Release”) that has become irrevocable within sixty (60) days following the later of the Change in Control or the Termination Date, then all of Executive’s Equity Awards subject to vesting based on performance (a “Performance-Based Equity Award”) shall be treated as follows:
(i)In the case of a Performance-Based Equity Award (or portion thereof) where performance is measured against the Company’s stock price or a similar market-based performance criteria (for example, relative total shareholder return), the Performance-Based Equity Award will fully accelerate as of the date of consummation of the Change in Control.
(ii)In the case of a Performance-Based Equity Award (or portion thereof) where performance is measured against a business performance metric that is not a market based metric (such as EBITDA, revenue, etc.), such performance criteria will be deemed satisfied at 100% of target for any unfinished performance period and such Performance-Based
4



Equity Award will convert to time-based vesting on a ratable basis for the remainder of the original performance period in the applicable Equity Award agreement, subject to the provisions of Section 4(b).
(iii)The portion of any Performance-Based Equity Award for which the performance condition is not deemed satisfied pursuant to this Section 4 (if any) will be forfeited. The effective date of the foregoing vesting credit and forfeiture will be the date of the Change in Control.
(b)Involuntary Termination in Connection with a Change in Control. If Executive’s employment with the Company terminates as a result of an Involuntary Termination either on or at any time within twelve months (12) months after a Change in Control, or within three (3) months prior to a Change in Control, and Executive signs and does not revoke a Release that has become irrevocable within sixty (60) days following the later of the Change in Control or the Termination Date, then Executive shall be entitled to the following severance benefits, subject to Section 9 below:
(i)150% of Executive’s annual base salary and target bonus (as in effect prior to any reduction that constitutes a basis for Involuntary Termination pursuant to this Agreement), payable in a lump sum on the sixtieth (60th) day following the later of the Termination Date or the Change in Control;
(ii)all of Executive’s outstanding Equity Awards subject to time-based vesting (including any Equity Awards converted to time-based vesting pursuant to Section 4(a)) will become fully vested and exercisable; provided, however, that notwithstanding any contrary term of the Equity Award agreement, if Executive is entitled to accelerated vesting under this Section 4(b) as a result of an Involuntary Termination within three (3) months prior to a Change in Control: (1) the portion of the Equity Award subject to such accelerated vesting shall not be forfeited or terminated upon the Termination Date pending the Change in Control, (2) the accelerated vesting shall be deemed to take place immediately prior to the effective date of the Change in Control, and (3) the period within which the Equity Award may be exercised following the Termination Date, if applicable, will expire no less than one (1) month following the effective date of the Change in Control (but no later than the expiration of the term of the Equity Award); and
(iii)a lump sum payment equal to eighteen (18) months of premiums under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, or corresponding provision of state law (“COBRA”) for health insurance coverage for Executive and Executive’s eligible dependents, at the same level and for the same eligible dependents covered as of Executive’s Termination Date. If Executive is eligible and chooses to continue health coverage through COBRA, Executive is solely responsible for timely electing COBRA continuing coverage and for making all COBRA premium payments. 
5.Involuntary Termination Apart from a Change in Control. If Executive’s employment with the Company terminates as a result of an Involuntary Termination that occurs more than three (3) months prior to or twelve (12) months after a Change in Control, and
5



Executive signs and does not revoke a Release that has become irrevocable within sixty (60) days following the Termination Date, then Executive shall be entitled to the following severance benefits, subject to Section 9 below:
(a)100% of Executive’s annual base salary and target bonus (as in effect prior to any reduction that constitutes a basis for Involuntary Termination pursuant to this Agreement), payable in a lump sum on the sixtieth (60th) day following the Termination Date; and
(b)a lump sum payment equal to twelve (12) months of premiums under COBRA for health insurance coverage for Executive and Executive’s eligible dependents, at the same level and for the same eligible dependents covered as of Executive’s Termination Date. If Executive is eligible and chooses to continue health coverage through COBRA, Executive is solely responsible for timely electing COBRA continuing coverage and for making all COBRA premium payments.
6.Mutually Exclusive Benefits. For the avoidance of doubt, the benefits afforded under Sections 4(b) and 5 are mutually exclusive. If Executive has an Involuntary Termination within three (3) months prior to a Change in Control and becomes entitled to cash severance pursuant to Section 4(b), but already received cash severance pursuant to Section 5, the amount of the cash severance payable pursuant to Section 4(b) shall be offset by the amount already paid, subject to compliance with Section 409A of the Code.
7.Accrued Wages and Vacation; Expenses. If Executive’s employment with the Company terminates, without regard to the reason for, or the timing of, Executive’s termination of employment, then (i) the Company shall pay Executive any unpaid wages due for periods prior to the Termination Date; (ii) the Company shall pay Executive all of Executive’s accrued and unused vacation through the Termination Date; and (iii) following submission of proper expense reports by Executive, the Company shall reimburse Executive for all expenses reasonably and necessarily incurred by Executive in connection with the business of the Company prior to the Termination Date. These payments shall be made promptly upon termination and within the period of time mandated by law.
8.Limitation on Payments. In the event that the severance and other benefits provided for in this Agreement or otherwise payable to Executive (i) constitute “parachute payments” within the meaning of Section 280G of the Code and (ii) would be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then Executive’s benefits under this Agreement shall be either:
(a)delivered in full or
(b)delivered as to such lesser extent which would result in no portion of such benefits being subject to the Excise Tax,
whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by Executive on an after-tax basis, of the
6



greatest amount of benefits, notwithstanding that all or some portion of such benefits may be taxable under Section 4999 of the Code.
Unless the Company and Executive otherwise agree in writing, any determination required under this Section 8 shall be made in writing by the Company’s independent public accountants (the “Accountants”), whose determination shall be conclusive and binding upon Executive and the Company for all purposes. For purposes of making the calculations required by this Section 8, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section 8. The Company shall bear all costs the Accountants may reasonably incur in connection with any calculations contemplated by this Section 8. In the event that a reduction is required, the reduction shall be applied first to any benefits that are not subject to Section 409A of the Code, and then shall be applied to benefits (if any) that are subject to Section 409A of the Code, with the benefits payable latest in time subject to reduction first.
9.Section 409A; Delayed Commencement of Benefits. The parties intend that any amounts payable hereunder comply with or are exempt from Section 409A of the Code (“Section 409A”), and this Agreement shall be administered accordingly. In the event that any changes to this Agreement or any additional terms are required to ensure that a payment is either exempt from or complies with Section 409A so that the penalty taxes under Section 409A(a)(1)(B) are not applied, you hereby agree that the Company may make such change or incorporate such terms (by reference or otherwise) without your consent. Each payment contemplated by this Agreement will be treated as a separate payment for purposes of Section 409A. Notwithstanding anything herein to the contrary, the Company shall have no liability to the Executive or to any other person if the payments and benefits provided in this Agreement that are intended to be exempt from or compliant with Section 409A are not so exempt or compliant, as applicable.
10.Successors.
(a)Company’s Successors. Any successor to the Company (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets shall assume the Company’s obligations under this Agreement and agree expressly to perform the Company’s obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term “Company” shall include any successor to the Company’s business and/or assets which executes and delivers the assumption agreement described in this subsection (a) or which becomes bound by the terms of this Agreement by operation of law.
(b)Executive’s Successors. Without the written consent of the Company, Executive shall not assign or transfer this Agreement or any right or obligation under this Agreement to any other person or entity. Notwithstanding the foregoing, the terms of this Agreement and all rights of Executive hereunder shall inure to the benefit of, and be enforceable
7



by, Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.
11.Notices.
(a)General. Notices and all other communications contemplated by this Agreement shall be in writing and shall be deemed to have been duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid. In the case of Executive, mailed notices shall be addressed to Executive at the home address which he most recently communicated to the Company in writing. In the case of the Company, mailed notices shall be addressed to its corporate headquarters, and all notices shall be directed to the attention of its Secretary.
(b)Notice of Termination. Any termination by the Company for Cause or by Executive as a result of an Involuntary Termination shall be communicated by a notice of termination to the other party hereto given in accordance with this Section 11. Such notice shall indicate the specific termination provision in this Agreement relied upon, shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so indicated, and shall specify the Termination Date (which shall be not more than thirty (30) days after the giving of such notice). The failure by Executive to include in the notice any fact or circumstance which contributes to a showing of Involuntary Termination shall not waive any right of Executive hereunder or preclude Executive from asserting such fact or circumstance in enforcing Executive’s rights hereunder, subject to the requirements of Section 1(e).
12.Arbitration. Any controversy involving the construction or application of any terms, covenants or conditions of this Agreement, or any claims arising out of any alleged breach of this Agreement, will be governed by the rules of the American Arbitration Association and submitted to and settled by final and binding arbitration in San Francisco, California, except that any alleged breach of Executive’s confidential information obligations shall not be submitted to arbitration and instead the Company may seek all legal and equitable remedies, including without limitation, injunctive relief.
13.Miscellaneous Provisions.
(a)No Duty to Mitigate. Executive shall not be required to mitigate the amount of any payment contemplated by this Agreement, nor shall any such payment be reduced by any earnings that Executive may receive from any other source.
(b)Waiver. No provision of this Agreement may be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.
8



(c)Integration. This Agreement supersedes and replaces any prior agreements, representation or understandings, whether written, oral, express or implied, between Executive and the Company and constitutes the entire agreement and understanding between the parties with respect to the subject matter hereof.
(d)Choice of Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the internal substantive laws, but not the conflicts of law rules, of the State of California.
(e)Severability. The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision hereof, which shall remain in full force and effect.
(f)Employment Taxes. All payments made pursuant to this Agreement shall be subject to withholding of applicable income and employment taxes.
(g)Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together will constitute one and the same instrument.
[SIGNATURE PAGE FOLLOWS]
9



IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer, as of the day and year first above written.


COMPANY:
PERFORMANT FINANCIAL CORPORATION

By: /s/ Lisa Im                    
Name: Lisa Im
Title: Executive Chair
EXECUTIVE:
/s/ Simeon Kohl                
Signature
Printed Name: Simeon Kohl
Title: Chief Executive Officer





EX-10.3 4 pfmt-employmentagreementra.htm EX-10.3 Document
Exhibit 10.3
EMPLOYMENT AGREEMENT
This Employment Agreement (the “Agreement”) is entered into by and between Performant Financial Corporation, a Delaware corporation (the “Company”) and Rohit Ramchandani (the “Executive”) dated as of April 26, 2024.
1.Position; Place of Work. Effective as of May 5, 2023 (the “Effective Date”) the Executive shall serve as the Company’s Chief Financial Officer (“CFO”), and also agrees to serve, if appointed or elected, as an officer or director of any other affiliate of the Company.
2.Duties and Responsibilities. The Executive’s primary duties and responsibilities will be those generally associated with the position of CFO, reporting to the Chief Executive Officer (“CEO”). The Executive shall perform such other duties as he may be assigned from time to time by the CEO or the Board of Directors of the Company (the “Board”). The Executive agrees to abide by the rules, regulations, personnel practices and policies of the Company and, as applicable, its affiliates, and any changes therein that may be adopted by them from time to time.
3.Devotion of Time to Business. The Executive shall devote such of the Executive’s professional time to the Executive’s employment as may be required to perform services hereunder and shall expend his best efforts on behalf of the Company.
4.Conflicts of Interest. In order to avoid conflicts of interest and inadvertent disclosure or improper use of Confidential information and to ensure that the Executive devotes his professional energies to his employment, while employed by the Company the Executive will not accept or engage in any professional employment, consulting or other service relationship with any business without first giving written notice to, and receiving written approval from, the Board.
5.Compensation.
a.Base Salary. As of the Effective Date, the Executive’s base salary shall be $290,000 per year on an annualized basis (“Base Salary”), which will be paid to the Executive in accordance with the Company’s normal payroll procedures.
b.Bonus. As of the Effective Date, the Executive’s target annual bonus (the “Performance Bonus”) will be 50% of the Executive’s Base Salary. The Performance Bonus will be earned by the achievement of one or more milestones to be set each year by the Board. The allocation of the Bonus to the various milestones and the terms on which the Performance Bonus will be earned will be set by the Board in its sole discretion. In order to earn any or all of the Performance Bonus for any given the Executive must be employed on the last day of the calendar year. The Performance Bonus will be paid on or before March 15 of the year following the year in which it is earned. If the Board does not pass a resolution establishing milestones and the allocation of the Performance Bonus by the end of the first quarter of any calendar year, the Performance Bonus for that year will be a discretionary Bonus.



c.Equity Award. The Executive and the Company acknowledge that in connection with his promotion to CFO, the Executive received a restricted stock unit award under the Company’s 2012 Stock Incentive Plan covering 216,724 shares of the Company’s common stock (the “RSU Award”), with (i) fifty-percent (50%) of the RSU Award vesting in four equal installments on each of the first four anniversaries of the Effective Date, subject to the Executive’s continued employment on each such date, and (ii) the remaining fifty-percent (50%) of the RSU Award subject to performance-based vesting conditions based on predetermined target prices for shares of the Company’s common stock. The Executive and the Company further acknowledge that the Executive received a subsequent restricted stock unit award under the Company’s 2012 Stock Incentive Plan on March 26, 2024 covering 52,817 shares of the Company’s common stock with such award vesting in four equal installments on each of the first four anniversaries of the grant date of such award. The Executive will also be eligible for future grants of equity compensation in the sole discretion of the Board or the Compensation Committee of the Board.
6.Benefits.
a.General. The Executive will be entitled to participate in all Company sponsored benefit and insurance programs to the extent that such benefits are offered generally to the Company’s employees in similar positions, with similar seniority. The terms of the Company’s benefit plans and programs are subject to change at any time in the Company’s sole discretion.
b.Term Life Insurance. The Company shall purchase a term life insurance policy insuring the life of the Executive with a death benefit of $1,000,000. The obligation of the Company to purchase such policy shall be conditioned on the Executive’s successful completion of any required medical examination(s) such that the policy can be bought at standard rates, and an annual premium not in excess of $3,500. The Executive shall, in his sole discretion, name the beneficiaries of the policy.
c.Expenses. The Company shall reimburse the Executive, in accordance with the Company’s policy, for all reasonable expenses incurred by the Executive in connection with the performance of the Executive’s duties. Reimbursement will be made within thirty (30) days of submission of a properly completed expense report with all receipts, but no later than March 15 of the year following the year in which such expense was incurred and the report submitted.
d.Paid Time Off. The Executive will be entitled to 4 weeks (20 days) paid vacation days per year. The Executive’s accrued paid vacation will be capped at 1.5 times his annual accrual. Once the Executive has hit the accrual cap, he will not accrue more vacation until he has reduced his accrued paid time off below the maximum accrual. Sick pay accrual will be in accordance with company policy and California law.
7.Confidential Information and Assignment to Company of Inventions. Prior to or contemporaneous with the execution of this Agreement the Executive has executed a Proprietary Information and Invention Assignment Agreement (the “IP Agreement”). Notwithstanding anything else contained herein, nothing in this Agreement is intended to or shall be construed to modify, impair or terminate any obligation of the Executive pursuant to the IP Agreement.
2


8.At-Will Employment. The Executive’s employment is “at-will.” This means that either the Executive or the Company may terminate the Executive’s employment under this Agreement at any time, with or without cause and with or without notice.
9.Change in Control and Severance Agreement. The Executive and the Company shall enter into a separate Change in Control and Severance Agreement contemporaneously with the execution of this Agreement.
10.Withholdings. All compensation payable to the Executive shall be subject to applicable taxes and withholdings.
11.Severability. The invalidity or unenforceability of any provision(s) of this Agreement under particular facts and circumstances will not affect the validity or enforceability either of other provisions of this Agreement or, under other facts and circumstances, of such provision(s). In addition, such provision(s) will be reformed to be less restrictive if under such facts and circumstances they would then be valid and enforceable.
12.Indemnification. The Executive will be provided indemnification to the maximum extent permitted by the Company’s Certificate of Incorporation or Bylaws, including, if applicable, any directors and officers insurance policies, with such indemnification to be on terms determined by the Board or any of its committees, but on terms no less favorable than provided to any other Company executive officer or director. Concurrently with the execution of this Agreement, the Company and the Executive will also enter into the Company’s standard form of indemnification agreement.
13.Sole and Only Agreement. This Agreement contains a complete statement of all agreements between the parties hereto with respect to its subject matter and except as expressly set forth herein supersedes all previous agreements, arrangements and understandings, written or oral, relating to its subject matter and cannot be changed or terminated except in writing, signed by the Executive and the Company.
14.Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of California.
15.No Waiver of Rights. The failure of a party to insist upon strict adherence to any term of this Agreement on any occasion shall not be considered a waiver or deprive that party of the right thereafter to insist upon adherence to that term or any other term of this Agreement. The waiver of a term or condition must be in writing executed by the party against whom the waiver is asserted.
16.Assignment of Rights. The Executive expressly acknowledges and agrees that Company’s rights under this Agreement may be transferred to or assigned by Company to a successor employer.
3


17.Consent to Arbitration. Except as prohibited by law, each party to this Agreement agrees that, any claim, controversy or legal dispute between them or between The Executive and any officer, director, shareholder, agent or employee of the Company, each of whom is hereby designated a third party beneficiary of this agreement regarding arbitration, (a “Dispute”) arising out of the Executive’s employment or termination of such employment or this Agreement will be resolved through binding arbitration in San Francisco, California in accordance with the then current Employment Arbitration Rules and Procedures Rules (the “Rules”) of the JAMS, Inc. which Rules are available for review at www.jamsadr.com and are incorporated herein by reference. Judgment upon the award rendered by the arbitrator in such proceeding may be entered in any court having jurisdiction thereof, provided, however, that the Law applicable to any issues regarding the scope, effectiveness or interpretation of this arbitration provision shall be the Federal Arbitration Act. This includes any claims the Executive may make relating to alleged discrimination or harassment during employment based on race, color, national origin, religion, disability, age, gender or sexual orientation, any claims relating to compensation (wages, bonuses, benefits, etc.) and any claims under federal state, or local laws or regulations relating to terms and conditions of employment. THE PARTIES HERETO UNDERSTAND THAT BY AGREEING TO ARBITRATE DISPUTES THEY ARE WAIVING ANY RIGHT TO A JURY TRIAL. The parties hereto agree that such arbitration shall be conducted on an individual basis only, not a class, representative or collective basis, and hereby waive any right to bring class wide, collective or representative claims before any arbitrator or in any forum. This arbitration provision is not intended to modify or limit the remedies available to either party, including the right to seek interim relief, such as injunction or attachment, through judicial process, which will not be deemed a waiver of the right to demand and obtain arbitration.
18.Attorneys’ Fees. In the event of any such arbitration or other legal proceeding, the prevailing party shall recover his or its reasonable attorneys’ fees, except expenses, and costs, excluding arbitration fees, to the extent permitted by law.
[Remainder of page intentionally left blank]

4


In Witness Whereof, the parties hereto have executed this Agreement.
PERFORMANT FINANCIAL CORPORATION
By: /s/ Lisa Im
Name: Lisa Im
Title: Executive Chair
Date:
EXECUTIVE:
/s/Rohit Ramchandani
Rohit Ramchandani
Date:


EX-10.4 5 changeinctrlseveranceagree.htm EX-10.4 Document
Exhibit 10.4
PERFORMANT FINANCIAL CORPORATION
CHANGE IN CONTROL AND SEVERANCE AGREEMENT
This Change in Control Severance Agreement (this “Agreement”) is made and entered into effective as of April 26, 2024 (the “Effective Date”), by and between Rohit Ramchandani (“Executive”) and Performant Financial Corporation, a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Section 1 below.
RECITALS
A.    It is expected that the Company from time to time will consider the possibility of a Change in Control. The Board of Directors of the Company (the “Board”) recognizes that such consideration can be a distraction to Executive and can cause Executive to consider alternative employment opportunities.
B.    The Board believes that it is in the best interests of the Company and its shareholders to provide Executive with an incentive to continue Executive’s employment and to maximize the value of the Company upon a Change in Control for the benefit of its shareholders.
C.    In order to provide Executive with enhanced financial security and sufficient encouragement to remain with the Company notwithstanding the possibility of a Change in Control, the Board believes that it is imperative to provide Executive with certain severance and other benefits upon Executive’s termination of employment in connection with a Change in Control.
D.    The Board also believes it is in the best interests of the Company and its shareholders to provide Executive with severance upon an involuntary termination other than in connection with a Change in Control.
AGREEMENT
In consideration of the mutual covenants herein contained and the continued employment of Executive by the Company, the parties agree as follows:
1.Definition of Terms. The following terms referred to in this Agreement shall have the following meanings:
(a)Cause. “Cause” shall mean Executive’s (i) commission of a felony, an act involving moral turpitude, or an act constituting common law fraud, and which has an adverse effect on the business or affairs of the Company or its affiliates or stockholders; (ii) intentional or willful misconduct or refusal to follow the lawful instructions of the Board that is not cured within thirty (30) days following written notice from the Board; (iii) commission of any violation of a company policy that has a material adverse effect on the business or reputation of the Company or (iv) intentional breach of Company confidential information obligations which has an adverse effect on the Company or its affiliates or stockholders. For these purposes, no act or failure to act shall be considered “intentional or willful” unless it is done, or omitted to be done,




in bad faith without a reasonable belief that the action or omission is in the best interests of the Company.
(b)Change in Control. “Change in Control” shall mean the occurrence of any of the following events:
(i)A change in the composition of the Board occurs, as a result of which fewer than one-half of the incumbent directors are directors who either:
(A)had been directors of the Company on the “look-back date” (as defined below) (the “original directors”); or
(B)were elected, or nominated for election, to the Board with the affirmative votes of at least a majority of the aggregate of the original directors who were still in office at the time of the election or nomination and the directors whose election or nomination was previously so approved (the “continuing directors”);
provided, however, that for this purpose, the “original directors” and “continuing directors” shall not include any individual whose initial assumption of office occurred as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents, by or on behalf of a person other than the Board; or
(ii)Any “person” (as defined below) who by the acquisition or aggregation of securities, is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934 (the “Exchange Act”)), directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company’s then outstanding securities ordinarily (and apart from rights accruing under special circumstances) having the right to vote at elections of directors (the “Base Capital Stock”); except that any change in the relative beneficial ownership of the Company’s securities by any person resulting solely from a reduction in the aggregate number of outstanding shares of Base Capital Stock, and any decrease thereafter in such person’s ownership of securities, shall be disregarded until such person increases in any manner, directly or indirectly, such person’s beneficial ownership of any securities of the Company; or
(iii)the consummation of a merger or consolidation of the Company or a Subsidiary of the Company with or into another entity or any other corporate reorganization, if persons who were not stockholders of the Company immediately prior to such merger, consolidation or other reorganization own immediately after such merger, consolidation or other reorganization 50% or more of the voting power of the outstanding securities of each of:
(A)the Company (or its successor) and
(B)any direct or indirect parent corporation of the Company (or its successor); or
2



(iv)The sale, transfer or other disposition of all or substantially all of the Company’s assets.
For purposes of subsection 1(b)(i) above, the term “look-back date” shall mean the date 24 months prior to the date of the event that may constitute a Change in Control.
For purposes of subsection 1(b)(ii)) above, the term “person” shall have the same meaning as when used in Sections 13(d) and 14(d) of the Exchange Act but shall exclude (1) a trustee or other fiduciary holding securities under an employee benefit plan maintained by the Company or a parent or subsidiary and (2) a corporation owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their ownership of the stock.
Any other provision of this Section 1(b) notwithstanding, a transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company’s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction, and a Change in Control shall not be deemed to occur if the Company files a registration statement with the United States Securities and Exchange Commission for the initial or secondary public offering of securities or debt of the Company to the public.
(c)Disability. “Disability” shall mean “disability” within the meaning of Section 22(e)(3) of the Code.
(d)Equity Award. “Equity Award” shall mean Executive’s awards of options, stock appreciation rights, restricted shares or stock units with respect to the Company or its successor, or the direct or indirect parent of either, or of any deferred compensation into which such stock options, stock appreciation rights, restricted shares or stock units were converted upon or prior to a Change in Control.
(e)Involuntary Termination. “Involuntary Termination” shall mean:
(i)a material reduction in Executive’s title, duties, authorities or responsibilities as the Chief Financial Officer of the Company without the Executive’s express written consent;
(ii)without Executive’s express written consent, a reduction by the Company of Executive’s base compensation of more than ten percent (10%), unless such reduction in base compensation is part of a general reduction in compensation applicable to senior executives of the Company;
(iii)without Executive’s express written consent, the relocation of Executive’s principal place of employment to a facility or a location more than fifty (50) miles from its location as of the Effective Date or, on or following a Change in Control, from its location immediately prior to such Change in Control; provided that Executive may not claim an Involuntary Termination if he is permitted to work remotely;
3



(iv)any termination of Executive by the Company which is not effected for Cause; or
(v)the failure of the Company to obtain the assumption of this Agreement or any other agreement between the Company and Executive by any successors contemplated in Section 10 below.
A termination shall not be considered an “Involuntary Termination” unless Executive provides notice to the Company of the existence of the condition described in subsections (i), (ii), (iii) or (iv) above within ninety (90) days of the initial existence of such condition, the Company fails to remedy the condition within thirty (30) days following the receipt of such notice, and Executive terminates employment within one-hundred eighty (180) days following the initial existence of such condition. A termination due to death or Disability shall not be considered an Involuntary Termination.
(f)Termination Date. “Termination Date” shall mean Executive’s “separation from service” within the meaning of that term under Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”).
2.Term of Agreement. This Agreement shall terminate on the third anniversary of the Effective Date, unless mutually renewed by the parties.
3.At-Will Employment. The Company and Executive acknowledge that Executive’s employment is and shall continue to be at-will, as defined under applicable law.
4.Change in Control Related Benefits.
(a)Effect of Change in Control on Performance-Based Equity Awards. If Executive is either employed at the time of a Change in Control or Executive’s employment with the Company terminates as a result of an Involuntary Termination on or within three (3) months prior to a Change in Control, and provided that in the case of such Involuntary Termination the Executive signs and does not revoke a release in a form approved by the Company (a “Release”) that has become irrevocable within sixty (60) days following the later of the Change in Control or the Termination Date, then all of Executive’s Equity Awards subject to vesting based on performance (a “Performance-Based Equity Award”) shall be treated as follows:
(i)In the case of a Performance-Based Equity Award (or portion thereof) where performance is measured against the Company’s stock price or a similar market-based performance criteria (for example, relative total shareholder return), the Performance-Based Equity Award will fully accelerate as of the date of consummation of the Change in Control.
(ii)In the case of a Performance-Based Equity Award (or portion thereof) where performance is measured against a business performance metric that is not a market based metric (such as EBITDA, revenue, etc.), such performance criteria will be deemed satisfied at 100% of target for any unfinished performance period and such Performance-Based
4



Equity Award will convert to time-based vesting on a ratable basis for the remainder of the original performance period in the applicable Equity Award agreement, subject to the provisions of Section 4(b).
(iii)The portion of any Performance-Based Equity Award for which the performance condition is not deemed satisfied pursuant to this Section 4 (if any) will be forfeited. The effective date of the foregoing vesting credit and forfeiture will be the date of the Change in Control.
(b)Involuntary Termination in Connection with a Change in Control. If Executive’s employment with the Company terminates as a result of an Involuntary Termination either on or at any time within twelve months (12) months after a Change in Control, or within three (3) months prior to a Change in Control, and Executive signs and does not revoke a Release that has become irrevocable within sixty (60) days following the later of the Change in Control or the Termination Date, then Executive shall be entitled to the following severance benefits, subject to Section 9 below:
(i)100% of Executive’s annual base salary and target bonus (as in effect prior to any reduction that constitutes a basis for Involuntary Termination pursuant to this Agreement), payable in a lump sum on the sixtieth (60th) day following the later of the Termination Date or the Change in Control;
(ii)all of Executive’s outstanding Equity Awards subject to time-based vesting (including any Equity Awards converted to time-based vesting pursuant to Section 4(a)) will become fully vested and exercisable; provided, however, that notwithstanding any contrary term of the Equity Award agreement, if Executive is entitled to accelerated vesting under this Section 4(b) as a result of an Involuntary Termination within three (3) months prior to a Change in Control: (1) the portion of the Equity Award subject to such accelerated vesting shall not be forfeited or terminated upon the Termination Date pending the Change in Control, (2) the accelerated vesting shall be deemed to take place immediately prior to the effective date of the Change in Control, and (3) the period within which the Equity Award may be exercised following the Termination Date, if applicable, will expire no less than one (1) month following the effective date of the Change in Control (but no later than the expiration of the term of the Equity Award); and
(iii)a lump sum payment equal to twelve (12) months of premiums under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, or corresponding provision of state law (“COBRA”) for health insurance coverage for Executive and Executive’s eligible dependents, at the same level and for the same eligible dependents covered as of Executive’s Termination Date. If Executive is eligible and chooses to continue health coverage through COBRA, Executive is solely responsible for timely electing COBRA continuing coverage and for making all COBRA premium payments. 
5.Involuntary Termination Apart from a Change in Control. If Executive’s employment with the Company terminates as a result of an Involuntary Termination that occurs more than three (3) months prior to or twelve (12) months after a Change in Control, and
5



Executive signs and does not revoke a Release that has become irrevocable within sixty (60) days following the Termination Date, then Executive shall be entitled to the following severance benefits, subject to Section 9 below:
(a)75% of Executive’s annual base salary and target bonus (as in effect prior to any reduction that constitutes a basis for Involuntary Termination pursuant to this Agreement), payable in a lump sum on the sixtieth (60th) day following the Termination Date; and
(b)a lump sum payment equal to nine (9) months of premiums under COBRA for health insurance coverage for Executive and Executive’s eligible dependents, at the same level and for the same eligible dependents covered as of Executive’s Termination Date. If Executive is eligible and chooses to continue health coverage through COBRA, Executive is solely responsible for timely electing COBRA continuing coverage and for making all COBRA premium payments.
6.Mutually Exclusive Benefits. For the avoidance of doubt, the benefits afforded under Sections 4(b) and 5 are mutually exclusive. If Executive has an Involuntary Termination within three (3) months prior to a Change in Control and becomes entitled to cash severance pursuant to Section 4(b), but already received cash severance pursuant to Section 5, the amount of the cash severance payable pursuant to Section 4(b) shall be offset by the amount already paid, subject to compliance with Section 409A of the Code.
7.Accrued Wages and Vacation; Expenses. If Executive’s employment with the Company terminates, without regard to the reason for, or the timing of, Executive’s termination of employment, then (i) the Company shall pay Executive any unpaid wages due for periods prior to the Termination Date; (ii) the Company shall pay Executive all of Executive’s accrued and unused vacation through the Termination Date; and (iii) following submission of proper expense reports by Executive, the Company shall reimburse Executive for all expenses reasonably and necessarily incurred by Executive in connection with the business of the Company prior to the Termination Date. These payments shall be made promptly upon termination and within the period of time mandated by law.
8.Limitation on Payments. In the event that the severance and other benefits provided for in this Agreement or otherwise payable to Executive (i) constitute “parachute payments” within the meaning of Section 280G of the Code and (ii) would be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then Executive’s benefits under this Agreement shall be either:
(a)delivered in full or
(b)delivered as to such lesser extent which would result in no portion of such benefits being subject to the Excise Tax,
whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by Executive on an after-tax basis, of the
6



greatest amount of benefits, notwithstanding that all or some portion of such benefits may be taxable under Section 4999 of the Code.
Unless the Company and Executive otherwise agree in writing, any determination required under this Section 8 shall be made in writing by the Company’s independent public accountants (the “Accountants”), whose determination shall be conclusive and binding upon Executive and the Company for all purposes. For purposes of making the calculations required by this Section 8, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive shall furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section 8. The Company shall bear all costs the Accountants may reasonably incur in connection with any calculations contemplated by this Section 8. In the event that a reduction is required, the reduction shall be applied first to any benefits that are not subject to Section 409A of the Code, and then shall be applied to benefits (if any) that are subject to Section 409A of the Code, with the benefits payable latest in time subject to reduction first.
9.Section 409A; Delayed Commencement of Benefits. The parties intend that any amounts payable hereunder comply with or are exempt from Section 409A of the Code (“Section 409A”), and this Agreement shall be administered accordingly. In the event that any changes to this Agreement or any additional terms are required to ensure that a payment is either exempt from or complies with Section 409A so that the penalty taxes under Section 409A(a)(1)(B) are not applied, you hereby agree that the Company may make such change or incorporate such terms (by reference or otherwise) without your consent. Each payment contemplated by this Agreement will be treated as a separate payment for purposes of Section 409A. Notwithstanding anything herein to the contrary, the Company shall have no liability to the Executive or to any other person if the payments and benefits provided in this Agreement that are intended to be exempt from or compliant with Section 409A are not so exempt or compliant, as applicable.
10.Successors.
(a)Company’s Successors. Any successor to the Company (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets shall assume the Company’s obligations under this Agreement and agree expressly to perform the Company’s obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term “Company” shall include any successor to the Company’s business and/or assets which executes and delivers the assumption agreement described in this subsection (a) or which becomes bound by the terms of this Agreement by operation of law.
(b)Executive’s Successors. Without the written consent of the Company, Executive shall not assign or transfer this Agreement or any right or obligation under this Agreement to any other person or entity. Notwithstanding the foregoing, the terms of this Agreement and all rights of Executive hereunder shall inure to the benefit of, and be enforceable
7



by, Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.
11.Notices.
(a)General. Notices and all other communications contemplated by this Agreement shall be in writing and shall be deemed to have been duly given when personally delivered or when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid. In the case of Executive, mailed notices shall be addressed to Executive at the home address which he most recently communicated to the Company in writing. In the case of the Company, mailed notices shall be addressed to its corporate headquarters, and all notices shall be directed to the attention of its Secretary.
(b)Notice of Termination. Any termination by the Company for Cause or by Executive as a result of an Involuntary Termination shall be communicated by a notice of termination to the other party hereto given in accordance with this Section 11. Such notice shall indicate the specific termination provision in this Agreement relied upon, shall set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so indicated, and shall specify the Termination Date (which shall be not more than thirty (30) days after the giving of such notice). The failure by Executive to include in the notice any fact or circumstance which contributes to a showing of Involuntary Termination shall not waive any right of Executive hereunder or preclude Executive from asserting such fact or circumstance in enforcing Executive’s rights hereunder, subject to the requirements of Section 1(e).
12.Arbitration. Any controversy involving the construction or application of any terms, covenants or conditions of this Agreement, or any claims arising out of any alleged breach of this Agreement, will be governed by the rules of the American Arbitration Association and submitted to and settled by final and binding arbitration in San Francisco, California, except that any alleged breach of Executive’s confidential information obligations shall not be submitted to arbitration and instead the Company may seek all legal and equitable remedies, including without limitation, injunctive relief.
13.Miscellaneous Provisions.
(a)No Duty to Mitigate. Executive shall not be required to mitigate the amount of any payment contemplated by this Agreement, nor shall any such payment be reduced by any earnings that Executive may receive from any other source.
(b)Waiver. No provision of this Agreement may be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.
8



(c)Integration. This Agreement supersedes and replaces any prior agreements, representation or understandings, whether written, oral, express or implied, between Executive and the Company and constitutes the entire agreement and understanding between the parties with respect to the subject matter hereof.
(d)Choice of Law. The validity, interpretation, construction and performance of this Agreement shall be governed by the internal substantive laws, but not the conflicts of law rules, of the State of California.
(e)Severability. The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision hereof, which shall remain in full force and effect.
(f)Employment Taxes. All payments made pursuant to this Agreement shall be subject to withholding of applicable income and employment taxes.
(g)Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together will constitute one and the same instrument.
[SIGNATURE PAGE FOLLOWS]
9



IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer, as of the day and year first above written.


COMPANY:
PERFORMANT FINANCIAL CORPORATION

By: /s/ Lisa Im                        
Name: Lisa Im
Title: Executive Chair
EXECUTIVE:
/s/Rohit Ramchandani                        
Signature
Printed Name: Rohit Ramchandani
Title: Chief Financial Officer